Nuclera Secures US$75m to Advance Protein Discovery System
Biotech firm Nuclera raises $75M to expand its cutting-edge protein discovery system, speeding up breakthroughs in labs worldwide.
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Michael Kuhrt contributed 541 entries already.
Biotech firm Nuclera raises $75M to expand its cutting-edge protein discovery system, speeding up breakthroughs in labs worldwide.
Efficiency and flexibility are key factors to stay competitive in the bioprocess field. With this aim in mind, the SciVario twin was envisioned as a tool to save time and costs during process development and optimization. All critical process parameters can be precisely controlled directly at the controller’s touch screen. The device is suitable for microbial and cell culture applications in both glass and single-use bioreactors. The innovative bay-drawer system enables flexible adaptation to unique requirements and changing processes. Frequent updates offered by Eppendorf, such as new functional modules, support for different bioreactor sizes and models, as well as additional software features, will help to enable the SciVario twin to serve your current and future bioprocessing needs.
A total of US$1bn was pledged to the WHO at this year’s World Health Summit in Berlin for the fight against Mpox, Marburg virus and the consequences of climate change.
Since 1995, the Eppendorf Award for Young European Investigators, endowed with €20,000, has honored outstanding achievements in the field of biomedical research in Europe once a year.
As a Contract Development and Manufacturing Organization (CDMO), mAbxience is committed to advancing biologics production and to ensuring that patients receive life-saving treatments faster and with uncompromising quality.
DFE Pharma, a world leader in excipients, has expanded into the biopharmaceutical market with its BioHale® portfolio, specifically designed for biologics.
Against the backdrop of Vienna’s historic charm, BIOTECH AUSTRIA, the association for the Austrian biotech industry,
recently invited leading industry representatives to the Vienna Stock Exchange to mark the third anniversary of the association.
Automation: SLAS empowers the global life sciences community to transform research by bringing interdisciplinary researchers and technology providers together to learn, solve challenges and advance life sciences innovation.
Expanding networks: Comprised of passionate individuals committed to driving positive change, YEBN board brings a wealth of diverse experiences and expertise to guide the association towards new heights of success.
Gabriella Björknert Caracciolo will leave Bactiguard AB, where she currently works as CFO and deputy CEO.

